•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Lineage Cell Therapeutics Q2 Earnings Call Highlights
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcript
Lineage Q2 Earnings Call Highlights
Compared to Estimates, Lineage, Inc. (LINE) Q2 Earnings: A Look at Key Metrics
Lineage, Inc. (LINE) Beats Q2 FFO and Revenue Estimates
Lineage, Inc. Reports Second-Quarter 2026 Financial Results
PREFORMED LINE PRODUCTS ANNOUNCES RECORD SECOND QUARTER 2026 FINANCIAL RESULTS
VALUE LINE, INC. ANNOUNCES HIGHER FISCAL YEAR 2026 EARNINGS
Aurora Mobile's GPTBots.ai Enhances Customer Service Solution with Audio Agent and LINE Plugin 2.0
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
Lineage: Don't Mistake A Cyclical Slump For A Broken Business
Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel
Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026
Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
Lineage vs. Rexford Industrial Realty: Which Real Estate Stock Is a Better Buy in 2026?
Lineage: Another Serious Fire Could Spell Trouble